D053127Living BeingsB04.820.545.405.400.900380.99656Influenza A Virus, H9N2 Subtypeprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMedicine-Hospital Medicine33050000Wang J, Prinz RA, Liu X, Xu XVirusesIn Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2. Viruses. 2020 10 08; 12(10).Viruses2020-10-08T00:00:002020In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2.11897066Uyeki TM, Chong YH, Katz JM, Lim W, Ho YY, Wang SS, Tsang TH, Au WW, Chan SC, Rowe T, Hu-Primmer J, Bell JC, Thompson WW, Bridges CB, Cox NJ, Mak KH, Fukuda KEmerging infectious diseasesLack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb; 8(2):154-9.Emerg Infect Dis2002-02-01T00:00:002002Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.0.384370.1455523research area of0.786130.1051648subject area forhttp://www.healthstats.orgCenter for Health StatisticsMedicineUniversity of ChicagoNancy JeanCox2WFmE4EXCuiXhHlsaUXv9Gq0+s+oNancy Jean Cox41.78927490000000-87.601250000000001011Cox, Nancy JeanEmeritus/EmeritaSusannahSpiessxHF5AqQGOeLWg25sc07h4WC08Nm6Susannah Spiess41.78927490000000-87.601250000000001012Spiess, SusannahRobertGibbonsRobert Gibbons41.78927490000000-87.60125000000000277Gibbons, RobertProfessortrue1true1Emeritus/EmeritaEmeritus/Emeritatrue1ProfessorProfessor23977250Krueger WS, Khuntirat B, Yoon IK, Blair PJ, Chittagarnpitch M, Putnam SD, Supawat K, Gibbons RV, Bhuddari D, Pattamadilok S, Sawanpanyalert P, Heil GL, Gray GCPloS oneProspective study of avian influenza virus infections among rural Thai villagers. PLoS One. 2013; 8(8):e72196.PLoS One2013-08-16T00:00:002013Prospective study of avian influenza virus infections among rural Thai villagers.14575127Chen H, Matsuoka Y, Chen Q, Cox NJ, Murphy BR, Subbarao KAvian diseasesGeneration and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate. Avian Dis. 2003; 47(3 Suppl):1127-30.Avian Dis2003-01-01T00:00:002003Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate.21680519Fusaro A, Monne I, Salviato A, Valastro V, Schivo A, Amarin NM, Gonzalez C, Ismail MM, Al-Ankari AR, Al-Blowi MH, Khan OA, Maken Ali AS, Hedayati A, Garcia Garcia J, Ziay GM, Shoushtari A, Al Qahtani KN, Capua I, Holmes EC, Cattoli GJournal of virologyPhylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J Virol. 2011 Aug; 85(16):8413-21.J Virol2011-06-15T00:00:002011Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications.